Nivolumab vs Tramadol
Nivolumab vs Tramadol: Overview
This comparison examines the pharmacological differences between Nivolumab and Tramadol.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Tramadol: Mu-opioid receptor agonist and serotonin-norepinephrine reuptake inhibitor.
Pharmacokinetics
Half-life: Nivolumab — 27 days; Tramadol — 5-7 hours.
Chemical Properties
Molecular Formula: Tramadol — C16H25NO2.
Molecular Weight: Tramadol — 263.3750 g/mol.
Type: Nivolumab — Antibody; Tramadol — Small molecule.